Literature DB >> 18362886

Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.

Hui-Yan Li1, Hui Liu, Chen-Hui Wang, Ji-Yan Zhang, Jiang-Hong Man, Yan-Fei Gao, Pei-Jing Zhang, Wei-Hua Li, Jie Zhao, Xin Pan, Tao Zhou, Wei-Li Gong, Ai-Ling Li, Xue-Min Zhang.   

Abstract

Despite rapid progress in elucidating the molecular mechanisms of activation of the kinase IKK, the processes that regulate IKK deactivation are still unknown. Here we demonstrate that CUE domain-containing 2 (CUEDC2) interacted with IKKalpha and IKKbeta and repressed activation of the transcription factor NF-kappaB by decreasing phosphorylation and activation of IKK. Notably, CUEDC2 also interacted with GADD34, a regulatory subunit of protein phosphatase 1 (PP1). We found that IKK, CUEDC2 and PP1 existed in a complex and that IKK was released from the complex in response to inflammatory stimuli such as tumor necrosis factor. CUEDC2 deactivated IKK by recruiting PP1 to the complex. Therefore, CUEDC2 acts as an adaptor protein to target IKK for dephosphorylation and inactivation by recruiting PP1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362886     DOI: 10.1038/ni.1600

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  64 in total

1.  Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells.

Authors:  Giovanna Clavarino; Nuno Cláudio; Alexandre Dalet; Seigo Terawaki; Thérèse Couderc; Lionel Chasson; Maurizio Ceppi; Enrico K Schmidt; Till Wenger; Marc Lecuit; Evelina Gatti; Philippe Pierre
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Authors:  Joanne Chew; Subhra Biswas; Sathyavageeswaran Shreeram; Mahathir Humaidi; Ee Tsin Wong; Manprit Kaur Dhillion; Hsiangling Teo; Amit Hazra; Cheok Chit Fang; Eduardo López-Collazo; Dmitry V Bulavin; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2009-04-19       Impact factor: 28.824

Review 3.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

4.  RACK1 modulates NF-κB activation by interfering with the interaction between TRAF2 and the IKK complex.

Authors:  Fan Yao; Ling-Yun Long; Yue-Zhen Deng; Yuan-Yuan Feng; Guo-Yuan Ying; Wen-Dai Bao; Guo Li; Dong-Xian Guan; Yin-Qiu Zhu; Jing-Jing Li; Dong Xie
Journal:  Cell Res       Date:  2013-12-10       Impact factor: 25.617

Review 5.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 6.  Mapping the crossroads of immune activation and cellular stress response pathways.

Authors:  Nuno Cláudio; Alexandre Dalet; Evelina Gatti; Philippe Pierre
Journal:  EMBO J       Date:  2013-04-12       Impact factor: 11.598

7.  Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.

Authors:  Yanzheng Tong; Jun Cui; Qingtian Li; Jia Zou; Helen Y Wang; Rong-Fu Wang
Journal:  Cell Res       Date:  2012-04-03       Impact factor: 25.617

8.  NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Authors:  Jun Cui; Liang Zhu; Xiaojun Xia; Helen Y Wang; Xavier Legras; Jun Hong; Jiabing Ji; Pingping Shen; Shu Zheng; Zhijian J Chen; Rong-Fu Wang
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

9.  NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.

Authors:  Xiaojun Xia; Jun Cui; Helen Y Wang; Liang Zhu; Satoko Matsueda; Qinfu Wang; Xiaoang Yang; Jun Hong; Zhou Songyang; Zhijian J Chen; Rong-Fu Wang
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

10.  A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ.

Authors:  Dong-Joo You; Cho Rong Park; Hyun Bok Lee; Mi Jin Moon; Ju-Hee Kang; Cheolju Lee; Seong-Hyun Oh; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.